// November 28, 2023
FDA's Draft Guidance for Topical Ophthalmic Drug Products: USP Standards
This year has seen a flurry of activity by the U.S.
This year has seen a flurry of activity by the U.S.
USP’s Naiffer Romero has teamed up with researchers at LHASA Limited, AstraZeneca, Sai Life S
(Disclaimer: The article below includes a discussion of key points of the guidance document.
This summer, a wave of regulatory activity on nitrosamines has taken place, with agencies fro